Osteoprotegerin Serum Levels in Abdominal Aortic Aneurysm  by Treska, Vladislav et al.
i
p
T
w
J
P
l
s
s
r
d
a
a
s
A
e
A
C
d
R
6
9
(
O
i
i
m
u
P
a
w
w
s
p
e
w
T
p
T
R
O
w
M
J
K
R
C
d
a
(
p
r
b
(
s
H
JOURNAL OF VASCULAR SURGERY
February 2011554 Abstractspraceliac aorta, superior mesenteric artery, renal arteries, and iliac artery
bifurcation. Median oral examination scores were 5% vs 87%, 26% vs 94%,
19% vs 86%, 30% vs 88%, and 29% vs. 87%, respectively (all P  .001) and
median or scores were 1.1 vs 2.9, 1.3 vs 3.5, 1.2 vs 3.2, 1.2 vs 3, and 1.5 vs
3.9, respectively (all P  .001).
Conclusions: Fresh cadaver laboratory sessions can provide a learner-
centered and safe environment for acquiring procedural understanding and
operative confidence of complex vascular exposures and allow for transfor-
mational change that is essential to becoming a competent vascular surgeon.
Osteoprotegerin Serum Levels in Abdominal Aortic Aneurysm
Vladislav Treska, Professor of Surgery, Ondrej Topolcan, Professor, Jindra
Vrzalova, Mgr, Jiri Molacek, Ass. Prof, Karel Houdek, MD, University
Hospital, Plzen, Czech Republic.
Objectives: Serum levels of osteoprotegerin (OPG) are a significant
marker for the prediction of cardiovascular disease severity and patient
mortality. Its association with abdominal aortic aneurysm (AAA) is still a
matter of discussion. The aim of our prospective nonrandomized study was
to find if any correlation existed between serum levels of OPG and AAA.
Methods: In 43 patients operated on for AAA, venous (peripheral
blood samples before operation) and arterial OPG serum levels (aneurysm
blood samples during open surgery) were evaluated by multiplex immuno-
analytic assay (xMAP) technology. Plasma OPG levels were correlated with
age, gender, diameter, and symptoms of AAA, hypertension, smoking,
diabetes mellitus, carotid artery stenoses, peripheral arterial stenoses, or
occlusions and AAA wall thrombus in multifactorial analysis. Twenty pa-
tients operated on for hernia served as a control group.
Results: OPG plasma levels were 1000 times higher in the AAA group
compared with controls. VenousOPG plasma levels were directly dependent
on AAA diameter (P  .01) and symptoms (P  .0005). Other important
factors for OPG plasma levels were smoking (P  .01) and age (P  .05).
Arterial plasma levels of OPG were significantly higher compared with
venous levels. Factors significant for arterial OPG plasma levels were age (P
 .01), hypertension (P  .05), and smoking (P  .03).
Conclusions: OPG venous levels are related to diameter and symptoms
of AAA. OPG should be used as a predictor of AAA growth in small AAAs
and also as a predictor of imminent AAA rupture. OPG is also a marker of
cardiovascular risk in smokers, diabetic patients, and those with carotid
artery stenosis, which is important for the type of operating procedure
decision making.
Interpreting the EVAR versus OPEN Repair Randomized Trials:
A Critical Meta-Analysis
Caron Rockman, MD, Maya Rubin, BA, Mark A. Adelman, MD, Frank
Veith, MD, Jeffrey S. Berger, MD, New York University Medical Center,
New York, NY.
Objectives: Although endovascular aneurysm repair (EVAR) has lower
perioperative mortality than open aortic aneurysm repair (OPEN), its ben-
efits may be compromised by an increase in secondary interventions and a
possible increase in late mortality. The goal of this study was to explore these
findings by performing an analysis of randomized controlled trials (RCTs)
comparing the outcomes of EVAR and OPEN.
Methods: A meta-analysis of RCTs comparing EVAR with OPEN was
performed, encompassing 2484 patients. Outcome measures included all-
cause mortality (early, late, total), AAA-related mortality (early, late, total),
graft-related complications, and secondary interventions.
Results: A total of 349 deaths (28.1%) occurred among 1243 EVAR
patients, and 367 deaths (29.6%) among 1241 OPEN patients. EVAR was
associated with a significant benefit in early all-cause mortality (1.3% vs
4.7%), with an odds ratio (OR) of 0.27 (95% confidence interval [CI],
0.15-0.49; P  .001). However, no significant differences were noted for
late all-cause mortality (OR, 1.04; 95% CI, 0.86-1.27; P  .67), or total
all-cause mortality (OR, 0.93; 95% CI, 0.77-1.12; P  .43). EVAR was
associated with a significant reduction in early AAA-related mortality (1.4%
vs 4.0%; OR, 0.36; 95% CI, 0.20-0.63; P .001). However, EVARwas also
associated with a significant increase in late AAA-related mortality (2.2% vs
0.9%; OR, 2.25; 95% CI, 1.11-4.56; P  .03). There was no significant
difference noted for total AAA-related mortality (3.5% vs 4.9%; OR, 0.73;
95% CI, 0.49-1.09; P  .13). EVAR was associated with a significant
increase in graft-related complications (40.1% vs 10.5%; OR, 6.01; 95% CI,
4.59-7.89, P  .001), and secondary interventions (19.2% vs 10.1%; OR,
2.12; 95% CI, 1.67-2.69; P  .001).
Conclusions: In pooled analysis of the RCTs comparing EVAR and
OPEN, EVAR has clear advantages of decreased early AAA-related and
all-cause mortality. Although the success of EVAR in reducing late AAA-
related mortality may be suboptimal, the importance of decreased early
mortality cannot be minimized, particularly from the patient’s perspective.
Future work must focus on improvements in design and techniques that will
decrease device-related complications and the need for secondary interven-
tions to further improve the long-term success of EVAR. Despite these
v
2ssues, EVAR remains the procedure of choice in anatomically suitable AAA
atients.
otally Robotic Aortic Surgery versus Robotic-Assisted Aortic Surgery
ith Mini-Laparotomy
udith C. Lin, MD, Sanjeev A. Kaul, MD, Akshay Bhandari, MD, James O.
eabody, MD, Mani Menon, MD, Henry Ford Hospital, Detroit, Mich.
Objectives: Safety and efficacy of totally laparoscopic aortic surgery and
aparoscopic-assisted aortic surgery with minilaparotomy have been demon-
trated in previous studies. Published reports of robotic-assisted aortic
urgery involve a combination of laparoscopy for aortic dissection and
obotic system for vascular reconstruction. The objective of this study is to
etermine the feasibility and advantage of a totally robotic aortic dissection
nd vascular reconstruction versus robotic-assisted aortic procedures for
ortoiliac occlusive disease (AIOD) and abdominal aortic aneurysm (AAA).
Methods: From February 2006 to August 2010, 21 patients were
elected for robotic aortic procedures: 12 had aortobifemoral bypass, 6 had
AA repairs, 1 had iliac aneurysm repair, and 2 had ligation of type II
ndoleak after endovascular aneurysm repair. Inclusion criteria included
AA 5 cm, iliac aneurysm 3 cm, and AIOD TransAtlantic InterSociety
onsensus C or D. The daVinci S Surgical System was used for the aortic
issection in all cases and the aortic anastomosis in three. Institutional
eview Board approval and informed consent were obtained.
Results: The 21 patients (6 women, 15 men) were an average age of
5.7 years (range, 44-86 years) and body mass index of 27.23 kg/m2, and
0.4% were American Society of Anesthesiology 3 or 4. Twenty patients
95.2%) underwent successful robotic dissection of the abdominal aorta.
ne patient underwent full conversion to open AAA repair due to trocar
njury. Of the remaining 20 patients, the average robotic dissection of the
nfrarenal aorta was 113.1 minutes and average aortic clamp time was 86
inutes. Procedures in 15 patients were performed with a minilaparotomy
sing an average abdominal incision of 13 cm to implant the Dacron or
TFE graft. Five patients underwent a totally robotic procedure with robotic
ortic reconstruction or ligation of type II endoleak. Thirty-day survival rate
as 100%. Median length of stay (LOS) was 7.5 days. All grafts were patent
ith a median follow-up of 26.5 months.
Conclusions: In this selected group of patients, totally robotic aortic
urgery for aortic dissection and vascular reconstruction is feasible. For aortic
rocedures completed total robotically without an abdominal incision, the
stimate blood loss was significantly less than robotic-assisted procedures
ith minilaparotomy.
able. Totally robotic versus robotic-assisted aortic
rocedures
Aortic clamp
time
Estimated
blood loss
(mL)
LOS
(days) Mini-incision
(min) (mL) (days) (cm)
otally robotic
(n  5)
60 200 6.6 None
obotic-assisted
(n  15)
89.5 1474.4 11.7 13
utcomes of EVAR in Hemodynamically Stable and Unstable Patients
ith Ruptured AAA: A Prospective Analysis
anish Mehta, MD, MPH, Sean P. Roddy, MD, Yaron Sternbach, MD,
ohn B. Taggert, MD, Paul B. Kreienberg, MD, Philip S.K. Paty, MD,
athleen J. Ozsvath, MD, Benjamin B. Chang, MD, Dhiraj M. Shah, MD,
. Clement Darling III, MD, Albany Medical College/Albany Medical
enter Hospital, Albany, NY.
Objectives: To date there are no published reports comparing hemo-
ynamically (Hd) stable and Hd unstable patients with ruptured abdominal
ortic aneurysms (r-AAA) undergoing endovascular aneurysm repair
EVAR). This study evaluated outcomes of EVAR for r-AAA based on
atient hemodynamic status
Methods: From 2002 to 2009, 106 patients with r-AAA were catego-
ized into two groups based on systolic blood pressure (SBP) measurements
efore EVAR: Hd-stable (SBP 80 mm Hg; n  72, 68%), and Hd-unstable
SBP 80 mm Hg; n  34, 32%). All data were prospectively collected, and
tatistical analysis was performed using 2 square and life-table methods
Results: Of the 106 r-AAA patients with EVAR, the Hd-stable and
d-unstable groups had similar comorbidities (coronary artery disease: 63%
s 59%, hypertension: 72% vs 75%, chronic obstructive pulmonary disease:
1% vs. 26%, and chronic renal insufficienc: 18% vs 18%), the need for
